1-12 of 12
Thomas S. Griffith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 718: Nanoparticle-based tumor cell lysate vaccine for cancer immunotherapy

Hyunjoon Kim, Peter Larson, Tamara A. Kucaba, Katherine A. Murphy, David M. Ferguson, Thomas S. Griffith, Jayanth Panyam
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 718.
https://doi.org/10.1158/1538-7445.AM2018-718
Published: 01 July 2018
View article titled, Abstract 718: Nanoparticle-based tumor cell lysate vaccine for cancer immunotherapy
Journal Articles

Abstract 2271: Effective therapy for advanced renal cell carcinoma using triptolide and TRAIL receptor agonists

Thomas S. Griffith, Erik L. Brincks, Tamara A. Kucaba, Britnie R. James, Veena Sangwan, Sulagna Banerjee, Ashok Saluja
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2271.
https://doi.org/10.1158/1538-7445.AM2014-2271
Published: 01 October 2014
View article titled, Abstract 2271: Effective therapy for advanced renal cell carcinoma using triptolide and TRAIL receptor agonists
Journal Articles

Abstract LB-459: Altered DC function during diet-induced obesity decreases the efficacy of antitumor immunotherapy

Lyse A. Norian, Tamara A. Kucaba, Britnie R. James, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-459.
https://doi.org/10.1158/1538-7445.AM2011-LB-459
Published: 15 April 2011
View article titled, Abstract LB-459: Altered DC function during diet-induced obesity decreases the efficacy of antitumor immunotherapy
Journal Articles

Activation of Tumor-Specific CD8+ T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy

Rebecca L. VanOosten, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2007) 67 (24): 11980–11990.
https://doi.org/10.1158/0008-5472.CAN-07-1526
Published: 18 December 2007
View article titled, Activation of Tumor-Specific CD8<sup>+</sup> T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy
Open the PDF for Activation of Tumor-Specific CD8<sup>+</sup> T Cells after Intratumoral Ad5-TRAIL/CpG Oligodeoxynucleotide Combination Therapy in another window
Journal Articles

Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Bladder Tumor Cells

James K. Earel, Jr., Rebecca L. VanOosten, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2006) 66 (1): 499–507.
https://doi.org/10.1158/0008-5472.CAN-05-3017
Published: 05 January 2006
View article titled, Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Bladder Tumor Cells
Open the PDF for Histone Deacetylase Inhibitors Modulate the Sensitivity of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Resistant Bladder Tumor Cells in another window
Journal Articles

Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression

Rebecca L. Van Oosten, Jill M. Moore, Bahri Karacay, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1268–1269.
Published: 01 May 2005
View article titled, Histone deacetylase inhibitors modulate renal cell carcinoma sensitivity to TRAIL/Apo-2L-induced apoptosis by enhancing TRAIL-R2 expression
Journal Articles

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

Rebecca L. Vanoosten, Jill M. Moore, Aaron T. Ludwig, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 412.
Published: 01 May 2005
View article titled, Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts
Journal Articles

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guérin (BCG) results in the release functional soluble TRAIL/Apo-2L

Thomas S. Griffith, Troy J. Kemp, Aaron T. Ludwig, James K. Earel, Jill M. Moore, Bonita Moses, Kevin Leidal, William M. Nauseef
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1268.
Published: 01 May 2005
View article titled, Neutrophil stimulation with <em>Mycobacterium bovis</em> bacillus Calmette-Guérin (BCG) results in the release functional soluble TRAIL/Apo-2L
Journal Articles

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: A Novel Mechanism for Bacillus Calmette-Guérin-Induced Antitumor Activity

Aaron T. Ludwig, Jill M. Moore, Yi Luo, Xiaohong Chen, Nicole A. Saltsgaver, Michael A. O’Donnell, Thomas S. Griffith
Journal: Cancer Research
Cancer Res (2004) 64 (10): 3386–3390.
https://doi.org/10.1158/0008-5472.CAN-04-0374
Published: 17 May 2004
View article titled, Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: <subtitle>A Novel Mechanism for Bacillus Calmette-Guérin-Induced Antitumor Activity</subtitle>
Open the PDF for Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand: <subtitle>A Novel Mechanism for Bacillus Calmette-Guérin-Induced Antitumor Activity</subtitle> in another window
Journal Articles

TRAIL mediated gene therapy of neuroblastoma is enhanced by simultaneous inhibition of NF-κB pathway

Bahri Karacay, Salih Sanlioglu, Thomas S. Griffith, Anthony Sandler, Daniel J. Bonthius
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1061.
Published: 01 April 2004
View article titled, TRAIL mediated gene therapy of neuroblastoma is enhanced by simultaneous inhibition of NF-κB pathway
Journal Articles

Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand

Moneeb Ehtesham, Peter Kabos, Mervin A. R. Gutierrez, Nancy H. C. Chung, Thomas S. Griffith, Keith L. Black, John S. Yu
Journal: Cancer Research
Cancer Res (2002) 62 (24): 7170–7174.
Published: 15 December 2002
View article titled, Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand
Open the PDF for Induction of Glioblastoma Apoptosis Using Neural Stem Cell-mediated Delivery of Tumor Necrosis Factor-related Apoptosis-inducing Ligand in another window
Journal Articles

Induction and Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Apo-2 Ligand-mediated Apoptosis in Renal Cell Carcinoma

Thomas S. Griffith, Jonathan M. Fialkov, David L. Scott, Takeo Azuhata, Richard D. Williams, Nathan R. Wall, Dario C. Altieri, Anthony D. Sandler
Journal: Cancer Research
Cancer Res (2002) 62 (11): 3093–3099.
Published: 01 June 2002
View article titled, Induction and Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Apo-2 Ligand-mediated Apoptosis in Renal Cell Carcinoma
Open the PDF for Induction and Regulation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand/Apo-2 Ligand-mediated Apoptosis in Renal Cell Carcinoma in another window